Skip to main content
CivicGate

HB 483 VA
To Executive

Prescription Drug Affordability Board; established.

VA · session 2026 · Assembly / House · bill

A state bill is a proposed law in a state legislature — separate from the U.S. Congress. Learn more →

Introduced Jan 12, 2026

Latest action (Apr 13, 2026) Governor's recommendation received by House

Summary

Prescription Drug Affordability Advisory Panel established; maximum fair price; annual reports; civil penalties. Directs the Secretary of Health and Human Resources to establish the Prescription Drug Affordability Advisory Panel to conduct data analyses, develop policy recommendations, and identify implementation barriers related to strategies to improve prescription drug affordability, enhance price transparency, and strengthen data collection practices for prescription drugs across public and private payers. The bill requires the Panel to (i) report annually on prescription drug pricing trends and any policy recommendations on legislation to improve prescription drug affordability and (ii) provide quarterly updates on prescription drug pricing trends. The bill requires each pharmacy benefits manager to provide to the Panel, upon request, certain information relating to the dispensation of a referenced drug, as defined in the bill.The bill prohibits prescription drug manufacturers or wholesale distributors permitted or licensed in the Commonwealth from accepting payment at an amount higher than the maximum fair price established by the U.S. Secretary of Health and Human Services pursuant to federal law for the sale of a referenced drug intended for use by individuals in the Commonwealth. Under the bill, an entity that violates such prohibition is subject to a civil penalty of $10,000 per violation. The bill also prohibits a manufacturer subject to its provisions from removing a referenced drug from sale distribution in the Commonwealth for the purpose of avoiding the impact of the bill's rate limitations without providing certain prior notice. Under the bill, a manufacturer that violates such prohibition on removing a referenced drug without the required notice is subject to a civil penalty equal to the greater of $100,000 or the total amount of annual savings for the referenced drug, as determined by the Board of Pharmacy. This bill is identical to SB 271.

Sponsor (1)

8 coauthors / cosponsors

Action history (41)

  1. Jan 12, 2026 Prefiled and ordered printed; Offered 01-14-2026 26104953D · lower
  2. Jan 12, 2026 Referred to Committee on Labor and Commerce · lower
  3. Jan 19, 2026 Assigned HCL sub: Subcommittee #1 · lower
  4. Jan 27, 2026 House subcommittee offered · lower
  5. Jan 27, 2026 Subcommittee recommends reporting with amendment(s) and referring to Appropriations (5-Y 4-N) · lower
  6. Jan 27, 2026 Fiscal Impact Statement from Department of Planning and Budget (HB483) · lower
  7. Jan 29, 2026 Reported from Labor and Commerce with amendment(s) and referred to Appropriations (14-Y 8-N) · lower
  8. Jan 30, 2026 Assigned HAPP sub: Health & Human Resources · lower
  9. Feb 6, 2026 Subcommittee recommends reporting (6-Y 1-N) · lower
  10. Feb 9, 2026 Reported from Appropriations (17-Y 5-N) · lower
  11. Feb 11, 2026 Read first time · lower
  12. Feb 12, 2026 Read second time · lower
  13. Feb 12, 2026 committee amendments agreed to · lower
  14. Feb 12, 2026 Engrossed by House as amended · lower
  15. Feb 13, 2026 Read third time and passed House (61-Y 33-N 0-A) · lower
  16. Feb 16, 2026 Constitutional reading dispensed (on 1st reading) · upper
  17. Feb 16, 2026 Referred to Committee on Commerce and Labor · upper
  18. Feb 17, 2026 Fiscal Impact Statement from Department of Planning and Budget (HB483) · lower
  19. Mar 9, 2026 Senate committee offered · upper
  20. Mar 9, 2026 Reported from Commerce and Labor with substitute and rereferred to Finance and Appropriations (12-Y 3-N) · upper
  21. Mar 9, 2026 Committee substitute printed 26109394D-S1 · upper
  22. Mar 9, 2026 Reported from Finance and Appropriations with substitute (10-Y 4-N) · upper
  23. Mar 10, 2026 Committee substitute printed 26109533D-S2 · upper
  24. Mar 10, 2026 Rules suspended · upper
  25. Mar 10, 2026 Constitutional reading dispensed (on 2nd reading) (37-Y 0-N 0-A) · upper
  26. Mar 10, 2026 Passed by for the day (Voice Vote) · upper
  27. Mar 11, 2026 Read third time · upper
  28. Mar 11, 2026 Commerce and Labor Substitute rejected · upper
  29. Mar 11, 2026 Finance and Appropriations Substitute agreed to · upper
  30. Mar 11, 2026 Engrossed by Senate - committee substitute · upper
  31. Mar 11, 2026 Passed Senate with substitute (34-Y 6-N 0-A) · upper
  32. Mar 12, 2026 Senate substitute agreed to by House (87-Y 11-N 0-A) · lower
  33. Mar 23, 2026 Fiscal Impact Statement from Department of Planning and Budget (HB483) · lower
  34. Mar 30, 2026 Enrolled · lower
  35. Mar 30, 2026 Bill text as passed House and Senate (HB483ER) · lower
  36. Mar 30, 2026 Signed by President · upper
  37. Mar 31, 2026 Fiscal Impact Statement from Department of Planning and Budget (HB483) · lower
  38. Mar 31, 2026 Signed by Speaker · lower
  39. Mar 31, 2026 Enrolled Bill communicated to Governor on March 31, 2026 · lower
  40. Mar 31, 2026 Governor's Action Deadline 11:59 p.m., April 13, 2026 · executive
  41. Apr 13, 2026 Governor's recommendation received by House · executive

Text versions (18)

The published texts of this bill as it moves through the legislature. Each links to the official document on the state legislature site. Data from OpenStates.

  • Governor Substitute · PDF
  • Governor Substitute · HTML
  • Governor's Recommendation · HTML
  • Enrolled · PDF
  • Enrolled · HTML
  • Finance and Appropriations Substitute · PDF
  • Finance and Appropriations Substitute · HTML
  • Commerce and Labor Substitute · PDF
  • Commerce and Labor Substitute · HTML
  • Commerce and Labor Substitute · PDF
  • Commerce and Labor Substitute · HTML
  • Engrossed · PDF
  • Engrossed · HTML
  • Labor and Commerce Amendment · HTML
  • Labor and Commerce Amendment · HTML
  • Subcommittee #1 Subcommittee Amendment · HTML
  • Introduced · PDF
  • Introduced · HTML

Full text

The full text hasn’t been imported yet. CivicGate fetches it from the state legislature’s published version documents — check now.

Comments

Comments

Loading comments…

Data from OpenStates. View on OpenStates →